Idarubicin plus ARA-C followed by allogeneic or autologous bone marrow transplantation in advanced acute lymphoblastic leukemia.
Arcese
W
W
Department of Human Biopathology, University La Sapienza, Rome.
Meloni
G
G
Giona
F
F
Vegna
M L
ML
Testi
A M
AM
Annino
L
L
Iori
A P
AP
Carotenuto
M
M
Resegotti
L
L
Madon
E
E
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D016026:Bone Marrow Transplantation; D003131:Combined Modality Therapy; D003561:Cytarabine / Q000008:administration & dosage; D006801:Humans; D015255:Idarubicin / Q000008:administration & dosage; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000188:drug therapy / Q000601:surgery / Q000628:therapy*; D011446:Prospective Studies; D012074:Remission Induction; D014182:Transplantation, Autologous; D014184:Transplantation, Homologous
D003561:Cytarabine; D015255:Idarubicin